益生菌在婴幼儿功能性胃肠病中的研究现状及展望

Research status and prospects of probiotics in functional gastrointestinal disorders in infants and toddlers

功能性胃肠病(functional gastrointestinal disorders,FGIDs)是儿科常见的消化系统疾病,严重时会影响婴幼儿的生长发育。益生菌治疗作为一种安全性较高的治疗手段,备受研究者的关注,但其在治疗婴幼儿FGIDs中的效果目前尚不清楚。该文综述了益生菌治疗婴幼儿FGIDs的机制及其相关研究,并探索各研究效果不一致的原因,以期为婴幼儿FGIDs的临床治疗和未来研究提供帮助。

Functional gastrointestinal disorders(FGIDs)are common digestive system diseases in children,which can severely afect the growth and development of infants and toddlers.Probiotics therapy,as a relatively safe treatment method,have attracted the attention of researchers.However,their effectiveness in treating FGIDs in infants and toddlers is still unclear.This article reviews the mechanisms of probiotics in treating FGIDs in infants and toddlers,explores the reasons for the inconsistency in various research results,and aims to provide assistance for the clinical treatment of FGIDs in infants and toddlers and future research.